# Organ-sparing With TraceIT® for Rectal Cancer Radiotherapy

> **NCT03258541** · NA · TERMINATED · sponsor: **Thomas Zilli** · enrollment: 2 (actual)

## Conditions studied

- Rectal Tumors
- Rectal Cancer
- Advanced Cancer

## Interventions

- **DEVICE:** TraceIT®
- **RADIATION:** Volumetric Arc Therapy (VMAT)
- **PROCEDURE:** Surgery

## Key facts

- **NCT ID:** NCT03258541
- **Lead sponsor:** Thomas Zilli
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-01-15
- **Primary completion:** 2020-05
- **Final completion:** 2020-05
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Surgical access not facilitated- residues of hydrogel.
- **Last updated:** 2020-05-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03258541

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03258541, "Organ-sparing With TraceIT® for Rectal Cancer Radiotherapy". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03258541. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*